SIGA Technologies (NASDAQ:SIGA - Get Free Report) released its earnings results on Tuesday. The company reported $0.63 earnings per share for the quarter, Zacks reports. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%.
SIGA Technologies Stock Down 1.9 %
Shares of SIGA traded down $0.11 during mid-day trading on Tuesday, hitting $5.60. 412,083 shares of the company's stock traded hands, compared to its average volume of 859,161. The firm has a market capitalization of $399.87 million, a P/E ratio of 4.67 and a beta of 0.98. The business's 50-day moving average price is $6.01 and its 200-day moving average price is $6.73. SIGA Technologies has a 1 year low of $4.75 and a 1 year high of $12.83.
About SIGA Technologies
(
Get Free Report)
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SIGA Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SIGA Technologies wasn't on the list.
While SIGA Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
